Share February 2023 Editor’s Choice: A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer

Copy link

February 02, 2023

February 2023 Editor’s Choice: A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer

27 minutes

Hosted by:
Wendy R. Brewster, MD, PhD, Deputy Editor of Gynecologic Oncology

Featuring:
Turgay Ayer, Georgia Institute of Technology
Tara Castellano, MD, Louisiana State University HSC
Isabel C. Scarinci, PhD, MPH, University of Alabama at Birmingham

Editor’s Choice Paper: Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer

Editorial: Targeting our efforts: the contribution of an open-access tool to assess geographic distribution of recurrent and metastatic cervical cancer

...more